Free Trial

Terumo (OTCMKTS:TRUMY) Shares Gap Down - Time to Sell?

Terumo logo with Medical background

Terumo Corp. (OTCMKTS:TRUMY - Get Free Report)'s share price gapped down prior to trading on Friday . The stock had previously closed at $17.97, but opened at $17.35. Terumo shares last traded at $17.92, with a volume of 69,230 shares changing hands.

Terumo Trading Down 0.6%

The company's 50-day moving average is $18.73 and its 200-day moving average is $18.81. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.78 and a current ratio of 3.00. The firm has a market cap of $26.45 billion, a price-to-earnings ratio of 34.36 and a beta of 0.80.

Terumo (OTCMKTS:TRUMY - Get Free Report) last announced its earnings results on Wednesday, May 14th. The company reported $0.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by ($0.07). Terumo had a return on equity of 8.48% and a net margin of 11.28%. The company had revenue of $1.79 billion for the quarter, compared to analyst estimates of $1.79 billion.

Terumo Company Profile

(Get Free Report)

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Terumo Right Now?

Before you consider Terumo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Terumo wasn't on the list.

While Terumo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines